Skip to main content
University of Wisconsin–Madison
UW Crest
Wisconsin Alzheimer's Institute
  • ABOUT Expand Collapse
    • About WAI
    • Contact Us
    • News and Events
    • Staff Directory
    • Work With Us
  • WAI MILWAUKEE Expand Collapse
    • About WAI Milwaukee
    • Contact
    • Our Services
    • Breaking the Silence
    • Amazing Grace Chorus
    • Addressing Systemic Racism Webinars
    • Support the Regional Milwaukee Office
  • CLINIC NETWORK Expand Collapse
    • About the Clinic Network
    • Annual Update in Alzheimer’s Disease
    • Memory Clinic Finder
    • Clinic Development
    • Clinic Network Events
    • Benefits of Clinic Network Affiliation
  • EDUCATION Expand Collapse
    • About WAI Education
    • WAI Summer Externship
    • Annual Update in Alzheimer’s Disease
    • Addressing Systemic Racism Webinars
    • New Friends Program
    • Updates in Dementia Care Newsletter
  • COMMUNITY HEALTH Expand Collapse
    • Dementia Capable Wisconsin
    • Improving Dementia Care with Education
    • Wisconsin Dementia Resource Network
  • RESEARCH Expand Collapse
    • About WAI Research
    • WRAP
    • IEA Innovation Fund
  • RESOURCES Expand Collapse
    • When to Seek Help
    • Benefits of Early Diagnosis
    • After a Dementia Diagnosis
    • Alzheimer’s and Dementia Resources
    • Speakers Bureau
  • Contact
  • Give
  1. Home
  2. WAI News

WAI News

Governor’s Health Equity Council releases 20 recommendations to build health equity in Wisconsin

Posted on March 1, 2023

Gina Green-Harris is chairperson of the Governor’s Health Equity Council

Posted in WAI News

Dr. Mora Pinzon discusses Alzheimer’s drug lecanemab on Telemundo Wisconsin

Posted on February 28, 2023

Maria Mora Pinzon, MD, MS, FACPM, recently appeared on Telemundo Wisconsin in a news segment discussing FDA approval of the drug lecanemab. The drug gained approval through an accelerated approval process in January 2023. Dr. …

Posted in WAI News

Announcing the IEA Innovation Fund

Posted on February 22, 2023

On behalf of the Initiative to End Alzheimer’s, we are pleased to announce the IEA Innovation Fund, providing project support for researchers at Wisconsin Alzheimer’s Institute and Wisconsin Alzheimer’s Disease Research Center. The fund was …

Posted in Uncategorized, WAI News

Video episode of Dementia Matters explores news and research on lecanemab

Posted on February 17, 2023

UW Alzheimer’s disease researchers Dr. Carlsson, Dr. Johnson and Dr. Chin discuss Alzheimer’s drug lecanemab in video episode of Dementia Matters podcast.

Posted in WAI News

Join us for coffee and a chat about healthy aging

Posted on February 15, 2023

Coffee and a Chat, a free, virtual event series. Join in from home – by computer or phone – and listen to health experts and ask questions.

Posted in WAI News

Applications for summer externs are now open!

Posted on February 3, 2023

First-year medical students are invited to apply today.

Posted in WAI News

Dr. Mora Pinzon appointed to assistant professor

Posted on February 2, 2023

Dr. Mora Pinzon’s work focuses on health services research in dementia care, and improving access to dementia care for Latinx individuals.

Posted in Uncategorized, WAI News

Dementia Matters episode discusses lecanemab, the latest Alzheimer’s drug to receive FDA accelerated approval

Posted on January 26, 2023

On a recent episode of the Dementia Matters podcast, host Nathaniel Chin, MD, gives an overview of the new Alzheimer’s treatment Leqembi (lecanemab), and highlights results from the second and third phases of its clinical trials.

Posted in Uncategorized, WAI News

Dr. Carlsson discusses approval of Alzheimer’s drug on CBS 58 news

Posted on January 11, 2023

Cynthia Carlsson, MD, MS, was recently interviewed by CBS 58 News in Milwaukee about the U.S. Food and Drug Administration (FDA) approval of Leqembi (lecanemab), which showed a reduction of clinical decline in a study …

Posted in WAI News

FDA approves Alzheimer’s disease drug lecanemab

Posted on January 10, 2023

On January 6, the U.S. Food and Drug Administration (FDA) approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway for the treatment of Alzheimer’s disease. Leqembi is the second of a new category of medications approved …

Posted in WAI News
  • You're on page 1
  • 2
  • 3
  • 12
  • Next page

Site footer content

University logo that links to main university website

Quick Links

  • About Wisconsin Alzheimer’s Institute
  • Contact WAI and WRAP
  • Staff Directory
  • News and Events
  • Give
  • For Employees

Contact Us

  • Email: wai@medicine.wisc.edu
    • facebook
    • twitter
    • youtube
    • linkedin

Website feedback, questions or accessibility issues: wai@medicine.wisc.edu.

Learn more about accessibility at UW–Madison.

This site was built using the UW Theme | Privacy Notice | © 2023 Board of Regents of the University of Wisconsin System.